A Challenge for Clinical Pharmacologists: How Can We Measure Scientific Impact of Publications in Drug Development and in Regulatory Decision Making?
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Paez A
. Gray literature: An important resource in systematic reviews. J Evid Based Med. 2017; 10(3):233-240.
DOI: 10.1111/jebm.12266.
View
2.
Bergman K
. The animal rule: The role of clinical pharmacology in determining an effective dose in humans. Clin Pharmacol Ther. 2015; 98(4):365-8.
DOI: 10.1002/cpt.172.
View
3.
Rekic D, Reynolds K, Zhao P, Zhang L, Yoshida K, Sachar M
. Clinical Drug-Drug Interaction Evaluations to Inform Drug Use and Enable Drug Access. J Pharm Sci. 2017; 106(9):2214-2218.
DOI: 10.1016/j.xphs.2017.04.016.
View
4.
Yoshida K, Zhao P, Zhang L, Abernethy D, Rekic D, Reynolds K
. In Vitro-In Vivo Extrapolation of Metabolism- and Transporter-Mediated Drug-Drug Interactions-Overview of Basic Prediction Methods. J Pharm Sci. 2017; 106(9):2209-2213.
DOI: 10.1016/j.xphs.2017.04.045.
View
5.
Maggio L, Meyer H, Artino Jr A
. Beyond Citation Rates: A Real-Time Impact Analysis of Health Professions Education Research Using Altmetrics. Acad Med. 2017; 92(10):1449-1455.
DOI: 10.1097/ACM.0000000000001897.
View